
    
      Two groups of patients will be assessed for the presence unique epigenetic signatures. The
      test group, having a bonafide diagnosis of rheumatoid arthritis (RA) and a control group of
      subjects who does not fulfill the American College of Rheumatology's classification criteria
      for RA. A buccal cell sample and blood draw will be sequenced and analyzed from each subject
      in each group for the presence of epigenetic signatures.
    
  